1pjp: Difference between revisions

New page: left|200px<br /> <applet load="1pjp" size="450" color="white" frame="true" align="right" spinBox="true" caption="1pjp, resolution 2.2Å" /> '''THE 2.2 A CRYSTAL ST...
 
No edit summary
 
(15 intermediate revisions by the same user not shown)
Line 1: Line 1:
[[Image:1pjp.gif|left|200px]]<br />
<applet load="1pjp" size="450" color="white" frame="true" align="right" spinBox="true"
caption="1pjp, resolution 2.2&Aring;" />
'''THE 2.2 A CRYSTAL STRUCTURE OF HUMAN CHYMASE IN COMPLEX WITH SUCCINYL-ALA-ALA-PRO-PHE-CHLOROMETHYLKETONE'''<br />


==Overview==
==THE 2.2 A CRYSTAL STRUCTURE OF HUMAN CHYMASE IN COMPLEX WITH SUCCINYL-ALA-ALA-PRO-PHE-CHLOROMETHYLKETONE==
Human chymase (HC) is a chymotrypsin-like serine proteinase expressed by, mast cells. The 2.2 A crystal structure of HC complexed to the peptidyl, inhibitor, succinyl-Ala-Ala-Pro-Phe-chloromethylketone (CMK), was solved, and refined to a crystallographic R-factor of 18.4 %. The HC structure, exhibits the typical folding pattern of a chymotrypsin-like serine, proteinase, and shows particularly similarity to rat chymase 2 (rat mast, cell proteinase II) and human cathepsin G. The peptidyl-CMK inhibitor is, covalently bound to the active-site residues Ser195 and His57; the, peptidyl moiety juxtaposes the S1 entrance frame segment 214-217 by, forming a short antiparallel beta-sheet. HC is a highly efficient, angiotensin-converting enzyme. Modeling of the chymase-angiotensin I, interaction guided by the geometry of the bound chloromethylketone, inhibitor indicates that the extended substrate binding site contains, features that may generate the dipeptidyl carboxypeptidase-like activity, needed for efficient cleavage and activation of the hormone. The, C-terminal carboxylate group of angiotensin I docked into the active-site, cleft, with the last two residues extending beyond the active site, is, perfectly localized to make a favorable hydrogen bond and salt bridge with, the amide nitrogen of the Lys40-Phe41 peptide bond and with the, epsilon-ammonium group of the Lys40 side-chain. This amide positioning is, unique to the chymase-related proteinases, and only chymases from primates, possess a Lys residue at position 40. Thus, the structure conveniently, explains the preferred conversion of angiotensin I to angiotensin II by, human chymase.
<StructureSection load='1pjp' size='340' side='right'caption='[[1pjp]], [[Resolution|resolution]] 2.20&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[1pjp]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1PJP OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1PJP FirstGlance]. <br>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.2&#8491;</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=0QE:CHLOROMETHANE'>0QE</scene>, <scene name='pdbligand=HPH:(2S)-2-AMINO-3-PHENYLPROPANE-1,1-DIOL'>HPH</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=SIN:SUCCINIC+ACID'>SIN</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1pjp FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1pjp OCA], [https://pdbe.org/1pjp PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1pjp RCSB], [https://www.ebi.ac.uk/pdbsum/1pjp PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1pjp ProSAT]</span></td></tr>
</table>
== Function ==
[https://www.uniprot.org/uniprot/CMA1_HUMAN CMA1_HUMAN] Major secreted protease of mast cells with suspected roles in vasoactive peptide generation, extracellular matrix degradation, and regulation of gland secretion.
== Evolutionary Conservation ==
[[Image:Consurf_key_small.gif|200px|right]]
Check<jmol>
  <jmolCheckbox>
    <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/pj/1pjp_consurf.spt"</scriptWhenChecked>
    <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked>
    <text>to colour the structure by Evolutionary Conservation</text>
  </jmolCheckbox>
</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=1pjp ConSurf].
<div style="clear:both"></div>
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
Human chymase (HC) is a chymotrypsin-like serine proteinase expressed by mast cells. The 2.2 A crystal structure of HC complexed to the peptidyl inhibitor, succinyl-Ala-Ala-Pro-Phe-chloromethylketone (CMK), was solved and refined to a crystallographic R-factor of 18.4 %. The HC structure exhibits the typical folding pattern of a chymotrypsin-like serine proteinase, and shows particularly similarity to rat chymase 2 (rat mast cell proteinase II) and human cathepsin G. The peptidyl-CMK inhibitor is covalently bound to the active-site residues Ser195 and His57; the peptidyl moiety juxtaposes the S1 entrance frame segment 214-217 by forming a short antiparallel beta-sheet. HC is a highly efficient angiotensin-converting enzyme. Modeling of the chymase-angiotensin I interaction guided by the geometry of the bound chloromethylketone inhibitor indicates that the extended substrate binding site contains features that may generate the dipeptidyl carboxypeptidase-like activity needed for efficient cleavage and activation of the hormone. The C-terminal carboxylate group of angiotensin I docked into the active-site cleft, with the last two residues extending beyond the active site, is perfectly localized to make a favorable hydrogen bond and salt bridge with the amide nitrogen of the Lys40-Phe41 peptide bond and with the epsilon-ammonium group of the Lys40 side-chain. This amide positioning is unique to the chymase-related proteinases, and only chymases from primates possess a Lys residue at position 40. Thus, the structure conveniently explains the preferred conversion of angiotensin I to angiotensin II by human chymase.


==About this Structure==
The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity.,Pereira PJ, Wang ZM, Rubin H, Huber R, Bode W, Schechter NM, Strobl S J Mol Biol. 1999 Feb 12;286(1):163-73. PMID:9931257<ref>PMID:9931257</ref>
1PJP is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with NAG and ZN as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Chymase Chymase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.39 3.4.21.39] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1PJP OCA].


==Reference==
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity., Pereira PJ, Wang ZM, Rubin H, Huber R, Bode W, Schechter NM, Strobl S, J Mol Biol. 1999 Feb 12;286(1):163-73. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=9931257 9931257]
</div>
[[Category: Chymase]]
<div class="pdbe-citations 1pjp" style="background-color:#fffaf0;"></div>
== References ==
<references/>
__TOC__
</StructureSection>
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Large Structures]]
[[Category: Bode, W.]]
[[Category: Bode W]]
[[Category: Huber, R.]]
[[Category: Huber R]]
[[Category: Pereira, P.J.B.]]
[[Category: Pereira PJB]]
[[Category: Rubin, H.]]
[[Category: Rubin H]]
[[Category: Schechter, N.M.]]
[[Category: Schechter NM]]
[[Category: Strobl, S.]]
[[Category: Strobl S]]
[[Category: Wang, Z.M.]]
[[Category: Wang ZM]]
[[Category: NAG]]
[[Category: ZN]]
[[Category: angiotensin]]
[[Category: dipeptidyl carboxypeptidase]]
[[Category: human chymase]]
[[Category: serine proteinase]]
 
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 18:43:54 2007''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA